Ecoflex-hydrogel bilayer soft robot for pH-controlled drug protection and delivery
Park H., Kim M., Lee Y., Lee S., Kim J., Yoon J.
Laboratory Study, published in Mater Today Bio (2026) — summary generated from the PubMed abstract.
Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.
- Level A · Stronger Clinical Evidence
- Level B · Emerging clinical evidence with positive signals
- Level C · Early human research exploring benefits
- Level D · Scientific groundwork from lab and animal studies
- Emerging · Emerging topic under active research
This page is generated from the PubMed record. The Thai description is an automated summary of bibliographic fields and the abstract, not a full translation, and is not medical advice.
- Study type
- Laboratory Study
- Journal
- Mater Today Bio (2026)
- Reported sample size
- —
- Source database
- Europe PMC
- PMID
- 42006728
- PMCID
- PMC13091027
- DOI
- 10.1016/j.mtbio.2026.103093
- Citations
- 1
Abstract (original English)
Conventional anticancer therapies remain limited by inadequate tumor-specific delivery and substantial off-target toxicity. Although hydrogel-based drug delivery systems offer high biocompatibility and tunable release profiles, their clinical translation is often impeded by uncontrolled diffusion and premature drug leakage inherent to their porous networks. Here, we introduce a multifunctional silicone-hydrogel bilayer soft robotic platform designed to achieve precise, stimuli-responsive drug delivery with enhanced retention and spatiotemporal control. Unlike conventional hydrogel-based systems, the proposed platform employs an Ecoflex-hydrogel bilayer architecture in which the elastomeric Ecoflex layer acts as a protective barrier that mechanically confines the hydrogel and suppresses premature drug leakage. The bilayer architecture integrates a hydrophobic silicone layer, which effectively suppresses unintended drug leakage, with a pH-responsive poly( N -isopropylacrylamide-co-acrylic acid) (p(NIPAM-co-AAc)) hydrogel layer that enables on-demand release via reversible swelling-deswelling behavior. Incorporation of magnetic iron(III) oxide (Fe 2 O 3 ) nanoparticles within the silicone matrix further allows remote, non-invasive actuation under external magnetic fields. The platform exhibits excellent thermal stability at physiological temperature (36.5 °C) and demonstrates sele
What this study does not prove
- • This study does not prove SVF is an approved treatment or a replacement for standard care.
- • This is preclinical work; animal or laboratory results cannot be applied to humans.
Evidence level
Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.
How we grade evidenceBrowse all related research
Filter the research library by this study's title keywords, author, or publication year.